Copyright
©The Author(s) 2020.
World J Clin Cases. Dec 6, 2020; 8(23): 6071-6079
Published online Dec 6, 2020. doi: 10.12998/wjcc.v8.i23.6071
Published online Dec 6, 2020. doi: 10.12998/wjcc.v8.i23.6071
Table 1 Literature review of retinopathy treatments related to Waldenström macroglobulinemia
Ref. | Number of cases | Systemic treatment | Local treatment | Outcome |
Fenicia et al[7], 2013 | 1 | None | One intravitreal injection of dexamethasone | Progressive slight reduction of SMD but no improvement of visual acuity |
Besirli et al[8], 2013 | 1 | Plasmapheresis and systemic chemotherapy | Intravitreal injections of bevacizumab, panretinal photocoagulation and intravitreal corticosteroid | Improvement of hyperviscosity retinopathy, unsuccessful in reversing the maculopathy |
Kapoor | 1 | Chemotherapy, plasmapheresis | Intravitreal bevacizumab | Complete resolution of intraretinal hemorrhages, complete resolution of all subretinal fluid |
Ratanam et al[10], 2015 | 1 | Plasmapheresis | Repeated intravitreal bevacizumab | Reduced macular edema |
- Citation: Li J, Zhang R, Gu F, Liu ZL, Sun P. Optical coherence tomography angiography characteristics in Waldenström macroglobulinemia retinopathy: A case report. World J Clin Cases 2020; 8(23): 6071-6079
- URL: https://www.wjgnet.com/2307-8960/full/v8/i23/6071.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i23.6071